Minerva Neuroscience
Cambridge
About Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options and a patient-centric focus. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with innovative mechanisms of action.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $131.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:NERV
- Website: minervaneurosciences.com
- Phone: (908)683-8300
Industries & Categories
Biopharma, Biotechnology, Health Care, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/minerva-neuroscience-128999 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.